CD8A and neoplasm: We also considered the possible role of immune cell activation in exerting the anti-tumor activity of miR146 and found that tumor tissues from HEXPO-miR146–treated ID8 mice had a higher density of CD8+ cells than did tumors from HEXPO-miRctrl treated mice.